Verona Pharma plc VRNA
Set alert
106.91 0.00 0.00%
At close · Oct 7
106.91 Day range 106.91
106.81 52-week range 106.93
- YTD
- +130.21%
- 1 year
- +233.99%
- Open
- 106.91
- Prev close
- 106.91
- Mkt cap
- 72.68B
- Vol
- 1.87M
- Avg vol
- 1.46M
- EPS
- -0.99
- P/E
- 872.73
- Div yield
- 0.00%
More statistics
- Low
- 106.91
- High
- 106.91
- Forward P/E
- -381.82
- Beta
- 0.05
- Short ratio
- 1.56
- Inst. own
- 92.23%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2025
- 50-d avg
- 105.95
- 200-d avg
- 79.84
- 1y target
- 0.00
6M chart
Events in this range
- Jul 1, 2025Rating: Wolfe Research · — → Outperform
- Jul 9, 2025Downgrade: Canaccord Genuity · Buy → Hold
- Jul 9, 2025Downgrade: Jefferies · Buy → Hold
- Jul 10, 2025Downgrade: BTIG · Buy → Neutral
- Jul 10, 2025Downgrade: Wells Fargo · Overweight → Equal-Weight
- Jul 14, 2025Downgrade: HC Wainwright & Co. · Buy → Neutral
Signals (17)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 1, 2025 | 1 year ago |
| RSI: Overbought | Sep 25, 2025 | 1 year ago |
| RSI: Overbought | Sep 2, 2025 | 1 year ago |
| RSI: Overbought | Aug 20, 2025 | 1 year ago |
| RSI: Overbought | Aug 18, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 10, 2025 | 1 year ago |
| RSI: Overbought | Jul 9, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 26, 2025 | 1 year ago |
| RSI: Overbought | May 30, 2025 | 1 year ago |
| MACD: Buy Signal | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| SMA: Bearish | May 9, 2025 | 1 year ago |
| MACD: Sell Signal | May 9, 2025 | 1 year ago |
| RSI: Overbought | Apr 29, 2025 | 1 year ago |
| SMA: Bullish | Apr 23, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 17, 2025 | 1 year ago |
Analyst view
Consensus: hold
Hold
Price target (mean) —
Ratings (0m) 6 0 buy · 6 hold · 0 sell
- Strong buy0
- Buy0
- Hold6
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 11
- 2 months ago 11
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 14, 2025 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Jul 10, 2025 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Jul 10, 2025 | BTIG | Downgrade | Buy | Neutral |
| Jul 9, 2025 | Jefferies | Downgrade | Buy | Hold |
| Jul 9, 2025 | Canaccord Genuity | Downgrade | Buy | Hold |
| Jul 1, 2025 | Wolfe Research | Initiated | — | Outperform |
| Jun 23, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Jun 20, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Jun 18, 2025 | Roth Capital | Reiterated | Buy | Buy |
| Jun 11, 2025 | Jefferies | Maintained | Buy | Buy |
| Jun 11, 2025 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Jun 2, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 30, 2025 | Jefferies | Maintained | Buy | Buy |
| Apr 30, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 30, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 28, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Feb 28, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 12, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Jan 21, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 10, 2025 | Roth MKM | Initiated | — | Buy |
| Jan 8, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Jan 8, 2025 | Truist Securities | Reiterated | Buy | Buy |
| Nov 5, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| Nov 5, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 5, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 9, 2024 | Truist Securities | Maintained | Buy | Buy |
| Oct 3, 2024 | Wells Fargo | Initiated | — | Overweight |
| Oct 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |